Literature DB >> 12428796

Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma.

Anna López-Ferrer1, Carlos Barranco, Carme de Bolós.   

Abstract

Mucins are highly O-glycosylated proteins synthesized by epithelial cells, and their glycosylation patterns can be altered during neoplastic transformation. The 2 types of non-small cell lung cancer (NSCLC) display a similar pattern of mucin gene expression but different reactivity to periodic acid-Schiff diastase, suggesting that a higher number of carbohydrate chains are present in adenocarcinomas. We compared the expression of core (Tn, sialyl-Tn, T) and terminal fucosylated and sialylated (Lewis antigens) carbohydrate structures in lung tumors. Specific antibodies were usedfor immunohistochemical and Western blot assays. Results indicated that core and terminal structures are detected more frequently in adenocarcinoma than in squamous cell carcinoma, except Lewis y, which is expressed strongly in both types of NSCLC. These data suggest that in squamous cell carcinoma and adenocarcinoma, different sets of glycosyltransferases must be expressed and that different posttranslational modifications of the mucin genes can take place in these 2 tumor types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428796     DOI: 10.1309/LWP3-MFA8-8KX7-60YQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Jung-Taek Kwon; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Sung-Jin Park; Hu-Lin Jiang; Ji-Hye Kim; Seong-Ho Hong; Bitna Kang; Duyeoul Kim; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Myung-Haing Cho
Journal:  Cell Oncol (Dordr)       Date:  2012-10-16       Impact factor: 6.730

Review 3.  Glycosylation Changes in Brain Cancer.

Authors:  Lucas Veillon; Christina Fakih; Hadi Abou-El-Hassan; Firas Kobeissy; Yehia Mechref
Journal:  ACS Chem Neurosci       Date:  2017-11-07       Impact factor: 4.418

4.  Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms.

Authors:  Jung-Hyun Rho; Michael H A Roehrl; Julia Y Wang
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371

Review 5.  The Role of Sialyl-Tn in Cancer.

Authors:  Jennifer Munkley
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

6.  Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer.

Authors:  Yiqian Liang; Peng Han; Ting Wang; Hui Ren; Lei Gao; Puyu Shi; Shuo Zhang; Aimin Yang; Zheng Li; Mingwei Chen
Journal:  Clin Proteomics       Date:  2019-05-10       Impact factor: 3.988

7.  Sialyl-tn in cancer: (how) did we miss the target?

Authors:  Sylvain Julien; Paula A Videira; Philippe Delannoy
Journal:  Biomolecules       Date:  2012-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.